BlackRock’s ROCHESTER MEDICAL CORP ROCM Stock Holding History

BlackRock’s Portfolio ROCM Stock Details ROCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-3,631	Closed	-$53K	–	3152
2013 Q2	$53K	Buy	+3,631	New	+$51.9K	﹤0.01%	1841

Other funds holding ROCM

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

LIM

Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

CCMU

Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

PGIM

Pacific Global Investment Management Glendale, California $70.7M AUM 14.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock's ROCM Position: Q3 2013 in Review

BlackRock sold out of ROCHESTER MEDICAL CORP (ROCM) in Q3 2013, closing a stake of 3,631 shares — an estimated $53K sold.

BlackRock first reported a position in ROCM in Q2 2013 and held it in 1 quarter. The position peaked at $53K in Q2 2013. 68 funds tracked by Wall St. Rank hold ROCM as of Q3 2013.

BlackRock reported no remaining ROCHESTER MEDICAL CORP position as of Q3 2013 after selling out during the quarter.
BlackRock sold 3,631 ROCHESTER MEDICAL CORP shares in Q3 2013, an estimated $53K.
BlackRock first reported a position in ROCHESTER MEDICAL CORP in Q2 2013 and held it in 1 quarter.
BlackRock's ROCHESTER MEDICAL CORP position peaked at $53K in Q2 2013.
68 funds tracked by Wall St. Rank held ROCHESTER MEDICAL CORP as of Q3 2013.

Based on BlackRock's 13F filing for Q3 2013, filed 12 Nov 2013.